Clinical Trial: Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143786) titled 'Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke' on Aug. 07.

Brief Summary: A phase I/IIa clinical trial investigating the safety and preliminary efficacy of intravenous administration of human induced neural stem cell-derived exosomes for acute ischemic stroke

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Ischemic Stroke, Acute

Intervention: DRUG: iNSC-EV01

Intravenous induced neural stem cell-derived exosome

DRUG: Placebo

iNSC-EV01 mimics

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Xuanwu Hospital, Beijing

Information provided by (Responsible Party): Junwei Hao, ...